These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 19493292)

  • 1. Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function.
    Jung JH; Jae SU; Kam SC; Hyun JS
    J Sex Med; 2009 Aug; 6(8):2299-304. PubMed ID: 19493292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
    Lee SH; Kim JC; Lee JY; Kim JH; Oh CY; Lee SW; Yoo SJ; Chung BH
    J Sex Med; 2009 Aug; 6(8):2292-8. PubMed ID: 19493291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a uroselective α1-blocker improves voiding and sexual function: a study in Thai men with lower urinary tract symptoms.
    Permpongkosol S; Krilad-O-Larn S; Ratana-O-Larn K
    J Sex Med; 2011 Sep; 8(9):2582-9. PubMed ID: 21699664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
    Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
    J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
    Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
    Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
    Shao Q; Song J; Guo YW; Lu WC; Du LD
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.
    Liguori G; Trombetta C; De Giorgi G; Pomara G; Maio G; Vecchio D; Ocello G; Ollandini G; Bucci S; Belgrano E
    J Sex Med; 2009 Feb; 6(2):544-52. PubMed ID: 19138360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction.
    Ströberg P; Boman H; Gellerstedt M; Hedelin H
    Scand J Urol Nephrol; 2006; 40(4):307-12. PubMed ID: 16916772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Shelbaia A; Elsaied WM; Elghamrawy H; Abdullah A; Salaheldin M
    Urology; 2013 Jul; 82(1):130-5. PubMed ID: 23711438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study.
    Lee JY; Cho SY; Oh CY; Ha US; Lee SH; Park SY; Moon HS; Lee SW
    Int J Impot Res; 2011; 23(6):249-56. PubMed ID: 21814227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sexual function of men with symptomatic benign prostatic hyperplasia and effect of Tamsulosin].
    Zhang JG; Wang YL; Ren XQ; Gao ZW; Cheng YH
    Zhonghua Nan Ke Xue; 2006 Aug; 12(8):723-5. PubMed ID: 16970165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
    Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.
    Seo DH; Kam SC; Hyun JS
    Korean J Urol; 2011 Jan; 52(1):49-54. PubMed ID: 21344031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Yan H; Zong H; Cui Y; Li N; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dysfunction in aging men with lower urinary tract symptoms.
    Mehraban D; Naderi GH; Yahyazadeh SR; Amirchaghmaghi M
    Urol J; 2008; 5(4):260-4. PubMed ID: 19101901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.